Nasdaq
MGX
Metagenomi Therapeutics, Inc.
- Health Care
- Listed 2024
- 1 day
- +2.1%
- 1 month
- −6.1%
- 1 year
- −41.0%
$1.24 · Mkt cap $46.7M
At the 6 Aug 2026 close
Nasdaq
Metagenomi Therapeutics, Inc.
$1.24 · Mkt cap $46.7M
At the 6 Aug 2026 close
Metagenomi Therapeutics, Inc. trades under the ticker MGX on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2024. Its market capitalisation is $46.7M. The last closing price was $1.24, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −41.0%, and −6.1% over the past month. Returns are price returns and exclude dividends.
This page exists because MGX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.